The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017
Authors
Keywords
Ontario, Age groups, Conjugate vaccines, Vaccines, Elderly, Canada, Infants, Vaccination and immunization
Journal
PLoS One
Volume 14, Issue 12, Pages e0226353
Publisher
Public Library of Science (PLoS)
Online
2019-12-14
DOI
10.1371/journal.pone.0226353
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of pneumococcal conjugate vaccine introduction on childhood pneumonia mortality in Brazil: a retrospective observational study
- (2019) Cynthia Schuck-Paim et al. Lancet Global Health
- Effect of Age on the Manifestations and Outcomes of Invasive Pneumococcal Disease in Adults
- (2018) Thomas J. Marrie et al. AMERICAN JOURNAL OF MEDICINE
- Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England
- (2018) Jo Southern et al. PLoS One
- Epidemiology of invasive pneumococcal disease in indigenous and non-indigenous adults in northwestern Ontario, Canada, 2006–2015
- (2018) Daniel Dalcin et al. BMC INFECTIOUS DISEASES
- Epidemiology of invasive pneumococcal and Haemophilus influenzae diseases in Northwestern Ontario, Canada, 2010–2015
- (2017) Vic Eton et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study
- (2017) Motoi Suzuki et al. LANCET INFECTIOUS DISEASES
- Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in South Africa
- (2017) Claire von Mollendorf et al. PLoS One
- Long-term trends in invasive pneumococcal disease in Manitoba, Canada
- (2017) Salaheddin M. Mahmud et al. Human Vaccines & Immunotherapeutics
- Impact of PCV13 on Serotype 3 Invasive Pneumococcal Disease and Nasopharyngeal Carriage in Massachusetts’ Children
- (2017) Rotem Lapidot et al. Open Forum Infectious Diseases
- Phylogenetic analysis of emergent Streptococcus pneumoniae serotype 22F causing invasive pneumococcal disease using whole genome sequencing
- (2017) Walter H. B. Demczuk et al. PLoS One
- Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain
- (2017) Jordi Càmara et al. PLoS One
- Population structure and drug resistance patterns of emerging non-PCV-13 Streptococcus pneumoniae serotypes 22F, 15A, and 8 isolated from adults in Ontario, Canada
- (2016) Venkata R. Duvvuri et al. INFECTION GENETICS AND EVOLUTION
- Association of serotype with respiratory presentations of pneumococcal infection, Ontario, Canada, 2003–2011
- (2016) Altynay Shigayeva et al. VACCINE
- Invasive Streptococcus pneumoniae in Canada, 2011–2014: Characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F
- (2016) Alyssa R. Golden et al. VACCINE
- Pneumococcal Capsules and Their Types: Past, Present, and Future
- (2015) K. Aaron Geno et al. CLINICAL MICROBIOLOGY REVIEWS
- Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance
- (2015) Matthew R Moore et al. LANCET INFECTIOUS DISEASES
- Impact of the 13-valent pneumococcal conjugate vaccine (pcv13) on invasive pneumococcal disease and carriage in Alaska
- (2015) Michael G. Bruce et al. VACCINE
- Direct and Indirect Effects of PCV13 on Nasopharyngeal Carriage of PCV13 Unique Pneumococcal Serotypes in Massachusetts’ Children
- (2014) Anita M. Loughlin et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Clinical and economic burden of invasive pneumococcal disease in adults: a multicenter hospital-based study
- (2013) Joon Young Song et al. BMC INFECTIOUS DISEASES
- Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012
- (2013) Walter H.B. Demczuk et al. CANADIAN JOURNAL OF MICROBIOLOGY
- Comparative Immunogenicity and Efficacy of 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines in Reducing Nasopharyngeal Colonization: A Randomized Double-Blind Trial
- (2013) Ron Dagan et al. CLINICAL INFECTIOUS DISEASES
- Pneumococcal infection in adults: burden of disease
- (2013) J.J.C. Drijkoningen et al. CLINICAL MICROBIOLOGY AND INFECTION
- Streptococcus pneumoniaeinfection: a Canadian perspective
- (2013) Xianding Deng et al. Expert Review of Anti-Infective Therapy
- Have changing pneumococcal vaccination programmes impacted disease in Ontario?
- (2013) Gillian H. Lim et al. VACCINE
- Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995–2011
- (2013) Wallis Rudnick et al. VACCINE
- Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia
- (2012) J. Burgos et al. CLINICAL MICROBIOLOGY AND INFECTION
- The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000–2007
- (2009) Julie A. Bettinger et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More